• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

    4/29/26 8:35:00 AM ET
    $BLTE
    $HCM
    $LOT
    $RADX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BLTE alert in real time by email

    NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Depositary Receipts Virtual Investor Conference ("dbVIC") held April 28th are now available for online viewing.

    VIEW PRESENTATIONS HERE

    The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company's resource section.

    April 28th Company Presentations

    • Lotus Technology Inc. (NASDAQ:LOT)
    • Viomi Technology Co., Ltd (NASDAQ:VIOT)
    • Belite Bio, Inc (NASDAQ:BLTE)
    • First Pacific Company Ltd ((HKEX: 142, OTC:FPAFY)
    • HUTCHMED (China) Limited (AIM: HCM, NASDAQ:HCM, and HKEX:13)
    • HEINEKEN N.V. (OTCQX:HEINY, Euronext Amsterdam: HEIA)) 
    • Yiren Digital Ltd. (NYSE:YRD)
    • Carrefour S.A. (PARIS:CA, OTC:CRRFY) 
    • Radiopharm Theranostics Ltd. (NASDAQ:RADX, ASX: RAD)) 
    • WeRide (NASDAQ:WRD, HKEX: 0800))

    To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

    About Virtual Investor Conferences®

    Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

    Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

    Media Contact: 

    OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com

    Virtual Investor Conferences Contact:

    Greg Young

    Investor Access

    OTC Markets Group

    T (212) 652-5958 M (917) 847-6541

    greg@otcmarkets.com



    Primary Logo

    Get the next $BLTE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BLTE
    $HCM
    $LOT
    $RADX

    CompanyDatePrice TargetRatingAnalyst
    Radiopharm Theranostics Limited
    $RADX
    6/4/2026$6.00Buy
    H.C. Wainwright
    WeRide Inc.
    $WRD
    3/31/2026$11.40Buy
    HSBC Securities
    WeRide Inc.
    $WRD
    3/26/2026$11.00Outperform
    BNP Paribas Exane
    WeRide Inc.
    $WRD
    2/10/2026$17.50Outperform
    Macquarie
    Belite Bio Inc
    $BLTE
    1/26/2026$195.00Buy
    BofA Securities
    Belite Bio Inc
    $BLTE
    1/6/2026$191.00Overweight
    Morgan Stanley
    WeRide Inc.
    $WRD
    1/5/2026$13.00Outperform
    CLSA
    Belite Bio Inc
    $BLTE
    12/2/2025$194.00Neutral → Outperform
    Mizuho
    More analyst ratings

    $BLTE
    $HCM
    $LOT
    $RADX
    SEC Filings

    View All

    SEC Form 6-K filed by WeRide Inc.

    6-K - WeRide Inc. (0001867729) (Filer)

    6/4/26 8:27:28 AM ET
    $WRD
    EDP Services
    Technology

    SEC Form 6-K filed by Lotus Technology Inc.

    6-K - Lotus Technology Inc. (0001962746) (Filer)

    6/3/26 5:25:18 PM ET
    $LOT
    Auto Manufacturing
    Industrials

    SEC Form 6-K filed by WeRide Inc.

    6-K - WeRide Inc. (0001867729) (Filer)

    6/3/26 8:32:38 AM ET
    $WRD
    EDP Services
    Technology

    $BLTE
    $HCM
    $LOT
    $RADX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $BLTE
    $HCM
    $LOT
    $RADX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $BLTE
    $HCM
    $LOT
    $RADX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    SEC Form 4 filed by Acting CEO and CFO Cheng Chig Fung

    4 - HUTCHMED (China) Ltd (0001648257) (Issuer)

    5/21/26 6:16:36 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Group General Counsel Nixon Charles George Rupert

    4 - HUTCHMED (China) Ltd (0001648257) (Issuer)

    5/21/26 6:11:26 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by CEO and CSO Su Wei-Guo

    4 - HUTCHMED (China) Ltd (0001648257) (Issuer)

    5/21/26 6:07:35 AM ET
    $HCM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lotus Tech Announces Change to Board Composition

    NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus Tech" or the "Company") (NASDAQ:LOT), a leading global intelligent and luxury mobility provider, today announced that the board of directors of the Company (the "Board") has appointed Mr. Joe Quan Zhang as a member and chairman of the Board and the compensation committee and the nominating and corporate governance committee of the Board, effective June 3, 2026. Mr. Zhang succeeded Mr. Daniel Donghui Li, who had served on the Board since the inception of the Company. During his time as chairman, Mr. Li played a pivotal role in guiding the business as Lotus Tech broadened its product range and expanded into new market

    6/3/26 5:30:00 PM ET
    $LOT
    Auto Manufacturing
    Industrials

    WeRide Included in Hong Kong Stock Connect Program, Expanding Access to Mainland China Investors

    SHANGHAI and SHENZHEN, China, June 03, 2026 (GLOBE NEWSWIRE) -- WeRide (NASDAQ:WRD, HKEX: 0800)), a global leader in autonomous driving technology, today announced its inclusion in the Hong Kong Stock Connect eligible securities list, effective June 4. The move enables eligible mainland China investors to trade WeRide shares listed on the Hong Kong Stock Exchange through the Hong Kong Stock Connect program. Shanghai Stock Exchange notice on the inclusion of WeRide under the Hong Kong Stock Connect eligible securities list Hong Kong Stock Connect is a mutual market access channel linking the mainland China and Hong Kong capital markets, with stringent eligibility requirements covering

    6/3/26 9:05:10 AM ET
    $WRD
    EDP Services
    Technology

    Lotus opens orders for Eletre X in mainland Europe

    Eletre X is built for drivers who refuse to compromise - delivering ultimate performance, 1,200+ km of range, and 9-minute charging in a practical hybrid SUV.1Available to order today, starting from €96,990. Supercar levels of performance in a practical SUV with a 900V architecture and up to 952 PS and 935 Nm of torque.No more range anxiety with EV-only range of up to 350 km; comprehensive range exceeding 1200 km (WLTP), without refuelling or charging.Ultra-fast charging with 70 kWh battery charging from 20–80% in just 9 minutes with 350 kW DC charger, making it one of the fastest charging electrified vehicles to come to market.Consistent performance in all driving conditions with 0-100 km/

    6/2/26 6:01:00 PM ET
    $LOT
    Auto Manufacturing
    Industrials

    H.C. Wainwright initiated coverage on Radiopharm Theranostics with a new price target

    H.C. Wainwright initiated coverage of Radiopharm Theranostics with a rating of Buy and set a new price target of $6.00

    6/4/26 8:45:49 AM ET
    $RADX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HSBC Securities initiated coverage on WeRide with a new price target

    HSBC Securities initiated coverage of WeRide with a rating of Buy and set a new price target of $11.40

    3/31/26 10:45:27 AM ET
    $WRD
    EDP Services
    Technology

    BNP Paribas Exane initiated coverage on WeRide with a new price target

    BNP Paribas Exane initiated coverage of WeRide with a rating of Outperform and set a new price target of $11.00

    3/26/26 8:52:50 AM ET
    $WRD
    EDP Services
    Technology

    $BLTE
    $HCM
    $LOT
    $RADX
    Financials

    Live finance-specific insights

    View All

    WRD 3.0 Becomes China's First Four-Time Urban Intelligent Driving Champion, WeRide Reports Record Q1 2026 Revenue, up 58% Year over Year

    NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- WeRide Inc. ("WeRide" or the "Company") (NASDAQ:WRD, HKEX: 0800)), a global leader in autonomous driving technology, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Total revenue was RMB114.1 million (US$16.5 million), representing an increase of 57.6% year over year. Product revenue was RMB20.5 million (US$3.0 million), representing an increase of 115.8% year over year, primarily attributable to increased revenue from robotaxi and other L4 vehicle sales.Service revenue was RMB93.7 million (US$13.6 million), representing an increase of 49.0% year over year. Gross

    5/13/26 5:40:00 AM ET
    $WRD
    EDP Services
    Technology

    WeRide to Report First Quarter 2026 Financial Results on Wednesday, May 13, 2026

    NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- WeRide Inc. ("WeRide" or the "Company") (NASDAQ:WRD, HKEX: 0800)), a global leader in autonomous driving technology, today announced that it will release its unaudited financial results for the first quarter 2026 on Wednesday, May 13, 2026, before the open of the U.S. markets. The Company's management will host an earnings conference call at 8:00 A.M. U.S. Eastern Time on May 13, 2026 or 8:00 P.M. Hong Kong Time on the same day to discuss the results. Details for the conference call are as follows: Event Title: WeRide Inc. First Quarter 2026 Earnings Call English Registration Link: https://register-conf.media-server.com/register/BI4f8923e8635

    4/30/26 5:35:00 AM ET
    $WRD
    EDP Services
    Technology

    Lotus Technology Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results

    Delivered 6,520 vehicles1 and achieved total revenue of $519 million in 2025.Service revenues increased 69% YoY in 2025, affirming the Company's technology edge and validating the commercialization of its intellectual property (IP).Gross margin improved to 9% in 2025 mainly due to the commencement of upgraded model deliveries globally and disciplined cost control.Operating loss narrowed by 65% YoY and 29% QoQ in the fourth quarter, with the full-year operating loss narrowed by 46% YoY, demonstrating the Company's commitment to operational efficiencies.Debut of Company's first PHEV model, named For Me (Eletre X in Europe), extending product roadmap and catering to evolving consumer demands ac

    4/10/26 6:00:00 AM ET
    $LOT
    Auto Manufacturing
    Industrials

    $BLTE
    $HCM
    $LOT
    $RADX
    Leadership Updates

    Live Leadership Updates

    View All

    Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update

    Initiated a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant for the treatment of Stargardt disease type 1 (STGD1); submission expected to be completed in the second quarter of 2026Commercialization preparation for STGD1 underway; hiring of all key commercial leadership positions completed Cash and cash equivalents, U.S. treasury bills and notes: $798.6 million as of March 31, 2026Conference call and webcast on Wednesday, May 20, 2026, at 4:30 p.m. ET SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio®" or the "Company"), a clinical-stage drug development company focused on advancing nov

    5/20/26 6:00:00 AM ET
    $BLTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LOTUS Appoints Piano Master Lang Lang as Friend of the Brand

    NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. ("Lotus Tech" or the "Company") (NASDAQ:LOT), a leading global intelligent and luxury mobility provider, today updated that LOTUS announced world-renowned pianist Lang Lang as its Friend of the Brand, marking a new partnership built on a shared pursuit of precision, performance, and excellence. Recognized globally for his extraordinary technique and expressive artistry, Lang Lang has brought classical music to audiences across cultures and generations. His dedication to mastery through discipline and refinement closely mirrors LOTUS's engineering philosophy, where every detail is shaped to deliver pure driving performance.

    2/6/26 8:30:00 AM ET
    $LOT
    Auto Manufacturing
    Industrials

    Viomi Technology Co., Ltd Appoints Malaysian Pop Star Shila Amzah as Brand Ambassador and Announces New AI Water Purifier Launch in Malaysia

    GUANGZHOU, China, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ:VIOT), a leading technology company for home water solutions in China, today announced the appointment of renowned Malaysian singer Ms. Shila Amzah as its brand ambassador in Malaysia. Ms. Amzah will join Viomi for a product launch event in Malaysia on October 30, where the Company will unveil its new AI water purifier, INNO, designed to bring a smarter and safer drinking water lifestyle to local households. Mr. Xiaoping Chen, Founder and CEO of Viomi, commented: "We are thrilled to welcome Ms. Shila Amzah as our brand ambassador in Malaysia. Together, at our upcoming product

    10/20/25 9:00:28 AM ET
    $VIOT
    Consumer Electronics/Appliances
    Consumer Discretionary

    $BLTE
    $HCM
    $LOT
    $RADX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Viomi Technology Co. Ltd

    SC 13G/A - Viomi Technology Co., Ltd (0001742770) (Subject)

    11/12/24 6:35:53 AM ET
    $VIOT
    Consumer Electronics/Appliances
    Consumer Discretionary

    SEC Form SC 13G filed by Lotus Technology Inc.

    SC 13G - Lotus Technology Inc. (0001962746) (Subject)

    11/12/24 6:07:58 AM ET
    $LOT
    Auto Manufacturing
    Industrials

    SEC Form SC 13G filed by Lotus Technology Inc.

    SC 13G - Lotus Technology Inc. (0001962746) (Subject)

    11/8/24 6:04:35 AM ET
    $LOT
    Auto Manufacturing
    Industrials